Spinal Implants Market report reviews top players & growth strategies

The global spinal implants market
is projected to reach USD 13.8 billion by 2025 from USD 10.3 billion in
2019, at a CAGR of 5.0%. Advancements in spine surgery technologies,
increasing incidence of spinal disorders, the launch of advanced bone
grafting products, and the increasing adoption of minimally invasive
spine surgeries are the major factors driving the growth of this
segment.

However, the high cost of spinal surgery is expected to restrain the growth of this market during the forecast period.

Download PDF Brochure: https://www.marketsandmarkets.com/pdfdownloadNew.asp?id=712

The
major players operating in the spinal implants market are Medtronic
(Ireland), DePuy Synthes (US), NuVasive, Inc. (US), Stryker Corporation
(US), B.

Braun Melsungen AG (Germany), Zimmer Biomet Holdings, Inc. (US), Globus Medical, Inc. (US), Orthofix International N.V.

(US),
Abbott Laboratories (US), RTI Surgical, Inc. (US), Boston Scientific
(US), SeaSpine Holdings Corporation (US), ulrich GmbH & Co.

KG
(Germany), Spineart (Switzerland), Kuros Biosciences AG (Switzerland),
Bioventus, LLC (US), Colfax Corporation (US), Meditech Spine, LLC (US),
and Implanet (France). The analysis of the market developments between
2016 and 2019 revealed that growth strategies such as product launches,
agreements, partnerships, and acquisitions were adopted by market
players to strengthen their product portfolios and maintain a
competitive position in the spinal implants market.

Among these business strategies, product launches was the most widely adopted growth strategy by market players.

Medtronic
(Ireland) dominated the global spinal implants and surgical devices
market in 2019, owing to its wide portfolio of spine surgery products
and strong geographical presence across the globe. The company primarily
focuses on developing technologically advanced products for minimally
invasive spine surgeries.

The key products offered by the company
include anterior cervical fusion products, bone grafts, artificial
cervical discs, electrosurgical products, posterior
occipitocervical-upper thoracic (OCT) reconstruction systems, and spinal
cord neurostimulation systems. The company is also pursuing the
strategy of acquisitions.

For instance, in January 2020, Medtronic
(Ireland) acquired Stimgenics, LLC (US), a pioneer in novel spinal cord
stimulation (SCS) waveform known as Differential Target Multiplexed
(DTM) Spinal Cord Stimulation. This acquisition was aimed at advancing
treatment for chronic pain.

Get Report Sample: https://www.marketsandmarkets.com/requestsampleNew.asp?id=712

DePuy Synthes (US) held the second position in the global spinal implants market
in 2019. The company has a strong geographical presence and offers a
broad range of products that are integral to the spinal implants and
surgical devices market.

The company primarily focuses on
strengthening its R&D capabilities to continuously develop and
commercialize innovative spine products in the global market. In line
with this strategy, the company launched various products in recent
years, such as Symphony Occipito-cervico-thoracic System (November
2019), CONDUIT Interbody Platform (September 2019), and Sentio MMG
(September 2018).

The company also pursues the strategy of
acquisitions. In September 2018, the company acquired Emerging Implant
Technologies GmbH (EIT).

This acquisition enabled DePuy Synthes to
enhance its comprehensive interbody implant portfolio, which includes
expandable interbody devices, titanium integrated PEEK technology, and
3D-printed cellular titanium, for both minimally invasive and open
spinal surgeries. Additionally, the company also acquired Interventional
Spine, Inc.

(US), a manufacturer of expandable cage and minimally
invasive surgery (MIS) technologies for spinal fusion. With this
acquisition, DePuy Synthes added a family of expandable cages to its
core spine platform.